ClinicalTrials.gg
Not yet recruitingNCT07862556Updated Oct 7, 2026

The Effects of an Evening Snack of Walnuts on Diet and Sleep Quality in Adolescents

An interventional study of Walnuts and Control (usual diet) in Diet Quality and Sleep, sponsored by Penn State University. Not yet recruiting at 1 site in United States. Open to participants aged 13 Years to 17 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-07.

Sponsored by Penn State University · Not applicable, Interventional, and Other

How we know

Updated Oct 7, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
13 Years to 17 Years
Sex
All
01

Study summary

The goal of this study is to examine whether an evening snack of 1 oz of walnuts consumed in place of usual evening snacks for 4 weeks has a beneficial effect on diet quality and sleep quality in adolescents age 13-17 years.

Read the detailed description

The goal of this study is to test the effects of an evening snack of 1 oz walnuts for four weeks, compared to habitual snacking behavior, on adolescent diet quality and sleep quality. Adolescents (age 13-17 years) will be assigned to complete the walnut intervention and habitual snack condition in a randomized, counterbalanced order, separated by a 4-week washout. Dietary quality will be measured using 24-hour recalls and the Healthy Eating Index, and sleep quality will be measured using actigraphy and daily survey reports of subjective sleep quality and daytime sleepiness. We hypothesize that during the walnut snacking condition, adolescents will have higher HEI scores and intakes of walnut-related nutrients, and higher sleep maintenance efficiency and subjective sleep quality, compared to during the habitual snack condition.

02

Conditions studied

  • Diet Quality
  • Sleep

Keywords

  • walnuts
  • sleep
  • diet quality
  • adolescents
  • snacking
03

In context

Lead sponsor

Penn State University is the lead sponsor of 271 studies on the registry; 54 are open to participants now.

Of its 15 completed or terminated interventional studies of FDA-regulated products, 11 (73%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
13 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Adolescent Inclusion Criteria:

  • Age 13 to 17 years
  • Enrolled in school (secondary education) that has defined start and end times (i.e., traditional in-person school or home/virtual school with a consistent schedule)
  • Consumes snacks in the evening (between dinner and sleep) on most nights
  • Able to read and answer questions in English

Adolescent Exclusion Criteria:

  • Sleep disorder (e.g., insomnia, sleep disordered breathing, narcolepsy)
  • Developmental disorder (e.g., autism, intellectual disability, developmental delay)
  • Diabetes
  • Any other medical condition impacting sleep or diet
  • Taking supplements or medications that affect sleep or eating behavior, including melatonin supplements
  • Current allergy or history of allergy to tree nuts or peanuts (any severity)
  • Other current severe food allergies
  • Unwilling to consume walnuts daily
  • Already consumes tree nuts 1 or more times per week
  • Parent/guardian not willing to participate

Parent Inclusion Criteria

  • Parent/guardian of a participating adolescent
  • Age 18 years or older
  • Able to read and answer questions in English

There are no additional exclusion criteria for parents

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
80 participants (estimated)

Study arms

  • Other
    Walnut then Control

    Participants will complete the walnut intervention first and the control period second

    Other: Walnuts · Other: Control (usual diet)

  • Other
    Control then Walnut

    Participants will complete the control period first and the walnut period second

    Other: Walnuts · Other: Control (usual diet)

Interventions

  • OtherWalnuts

    Participants will replace their usual evening snack(s) with 1 oz of walnuts each evening for 4 weeks.

  • OtherControl (usual diet)

    Participants will maintain their usual snacking behavior/diet

06

What researchers measure

Primary outcomes

  1. Health Eating Index score

    Healthy Eating Index will be calculated from 24-hour recalls completed using the NIH ASA-24 system. The effect of the intervention will be determined as the difference of baseline-post change for the walnut intervention period and the baseline-post change for the habitual snack control period.

    Time frame: Baseline and end of 4 week study period for both the walnut intervention and the habitual snack control period (4 time points total)

  2. Sleep maintenance efficiency

    Sleep maintenance efficiency is a metric of sleep quality that is defined as the percentage of the overnight sleep interval that is spent actually asleep. Sleep maintenance efficiency will be measured using wrist actigraphy over 2-week periods at baseline and post-intervention for both the walnut intervention period and habitual snack control period. The effect of the intervention will be defined as the difference of baseline-post change for the walnut intervention period and the baseline-post change for the habitual snack control period.

    Time frame: Two-week measurement bursts immediately prior to and end at the end of 4-week study period for both the walnut intervention and the habitual snack control period (4 time points/8 weeks total)

Secondary outcomes

  1. Healthy Eating Index - Seafood & Plant Protein component score

    Healthy Eating Index (HEI) Seafood \& Plant Protein component score will be calculated from 24-hour recalls completed using the NIH ASA-24 system. The effect of the intervention will be determined as the difference of baseline-post change for the walnut intervention period and the baseline-post change for the habitual snack control period.

    Time frame: Baseline and end of 4 week study period for both the walnut intervention and the habitual snack control period (4 time points total)

  2. Healthy Eating Index - Fatty Acid component score

    Healthy Eating Index (HEI) Fatty Acid will be calculated from 24-hour recalls completed using the NIH ASA-24 system. The effect of the intervention will be determined as the difference of baseline-post change for the walnut intervention period and the baseline-post change for the habitual snack control period.

    Time frame: Baseline and end of 4 week study period for both the walnut intervention and the habitual snack control period (4 time points total)

  3. Healthy Eating Index - Sodium component score

    Healthy Eating Index - Sodium component score will be calculated from 24-hour recalls completed using the NIH ASA-24 system. The effect of the intervention will be determined as the difference of baseline-post change for the walnut intervention period and the baseline-post change for the habitual snack control period

    Time frame: Baseline and end of 4 week study period for both the walnut intervention and the habitual snack control period (4 time points total)

  4. Healthy Eating Index - Refined Grains component score

    Healthy Eating Index - Refined Grains component score will be calculated from 24-hour recalls completed using the NIH ASA-24 system. The effect of the intervention will be determined as the difference of baseline-post change for the walnut intervention period and the baseline-post change for the habitual snack control period

    Time frame: Baseline and end of 4 week study period for both the walnut intervention and the habitual snack control period (4 time points total)

  5. Healthy Eating Index - Added Sugar component score

    Healthy Eating Index - Added sugar component score will be calculated from 24-hour recalls completed using the NIH ASA-24 system. The effect of the intervention will be determined as the difference of baseline-post change for the walnut intervention period and the baseline-post change for the habitual snack control period

    Time frame: Baseline and end of 4 week study period for both the walnut intervention and the habitual snack control period (4 time points total)

  6. Dietary intake of alpha-linolenic acid

    Dietary intake of alpha-linolenic acid (ALA) will be calculated from 24-hour recalls completed using the NIH ASA-24 system. The effect of the intervention will be determined as the difference of baseline-post change for the walnut intervention period and the baseline-post change for the habitual snack control period.

    Time frame: Baseline and end of 4 week study period for both the walnut intervention and the habitual snack control period (4 time points total)

  7. Dietary intake of magnesium

    Dietary intake of magnesium will be calculated from 24-hour recalls completed using the NIH ASA-24 system. The effect of the intervention will be determined as the difference of baseline-post change for the walnut intervention period and the baseline-post change for the habitual snack control period.

    Time frame: Baseline and end of 4 week study period for both the walnut intervention and the habitual snack control period (4 time points total)

  8. Dietary intake of fiber

    Dietary intake of fiber will be calculated from 24-hour recalls completed using the NIH ASA-24 system. The effect of the intervention will be determined as the difference of baseline-post change for the walnut intervention period and the baseline-post change for the habitual snack control period.

    Time frame: Baseline and end of 4 week study period for both the walnut intervention and the habitual snack control period (4 time points total)

  9. Sleep duration

    Sleep duration (hours/day) will be measured using wrist actigraphy over 2-week periods at baseline and post-intervention for both the walnut intervention period and habitual snack control period. The effect of the intervention will be defined as the difference of baseline-post change for the walnut intervention period and the baseline-post change for the habitual snack control period.

    Time frame: Two-week measurement bursts immediately prior to and end at the end of 4-week study period for both the walnut intervention and the habitual snack control period (4 time points/8 weeks total)

  10. Daytime sleepiness

    Participants will rate their level of daytime sleepiness as part of a diary survey completed each evening during 2-week periods at baseline and post-intervention for both the walnut intervention period and habitual snack control period. The effect of the intervention will be defined as the difference of baseline-post change for the walnut intervention and the baseline-post change for the habitual snack control period.

    Time frame: Two-week measurement bursts immediately prior to and end at the end of 4-week study period for both the walnut intervention and the habitual snack control period (4 time points/8 weeks total)

Other outcomes

  1. Sleep timing

    Sleep onset, midpoint, and offset will be measured using wrist actigraphy over 2-week periods at baseline and post-intervention for both the walnut intervention period and habitual snack control period. The effect of the intervention will be defined as the difference of baseline-post change for the walnut intervention period and the baseline-post change for the habitual snack control period.

    Time frame: Two-week measurement bursts immediately prior to and end at the end of 4-week study period for both the walnut intervention and the habitual snack control period (4 time points/8 weeks total)

  2. Variability of sleep maintenance efficiency

    Individual standard deviation of nightly sleep maintenance efficiency during each 2-week measurement burst. This is a metric of within-individual variability of sleep quality. The effect of the intervention will be defined as the difference of baseline-post change for the walnut intervention period and the baseline-post change for the habitual snack control period.

    Time frame: Two-week measurement bursts immediately prior to and end at the end of 4-week study period for both the walnut intervention and the habitual snack control period (4 time points/8 weeks total)

  3. Variability of sleep duration

    Individual standard deviation of nightly sleep duration during each 2-week measurement burst. This is a metric of within-individual variability of sleep duration. The effect of the intervention will be defined as the difference of baseline-post change for the walnut intervention period and the baseline-post change for the habitual snack control period.

    Time frame: Two-week measurement bursts immediately prior to and end at the end of 4-week study period for both the walnut intervention and the habitual snack control period (4 time points/8 weeks total)

  4. Variability of sleep timing

    Individual standard deviation of sleep onset, midpoint, and offset during each 2-week measurement burst. This is a metric of within-individual variability of sleep timing. The effect of the intervention will be defined as the difference of baseline-post change for the walnut intervention period and the baseline-post change for the habitual snack control period.

    Time frame: Two-week measurement bursts immediately prior to and end at the end of 4-week study period for both the walnut intervention and the habitual snack control period (4 time points/8 weeks total)

07

Study locations

1 site
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — Deidentified research data

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Analytic code

Time frame: Data will be made available at the conclusion of the study following publication of primary outcomes, and will be available indefinitely.

Access criteria: Data will be made available to the public through Ag Data Commons.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Jan 2027; primary completion for May 2028, 16 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 1, 2026
First posted
Oct 7, 2026
StartEst.
Jan 2027
Primary completionEst.
May 2028
CompletionEst.
May 2028
Last update
Oct 7, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 7, 2026
Show all 1 update
  1. Oct 7, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07862556
Responsible party
Emily Hohman (Associate Research Professor, Penn State University) — Principal investigator
First posted
Oct 7, 2026
Start date
Jan 2027 (estimated)
Primary completion
May 2028 (estimated)
Completion
May 2028 (estimated)
Last update
Oct 7, 2026

Study contacts

Emily E Hohman, PhD
Contact
eeh12@psu.edu
814-865-5245
Lindsey B. Hess, MPH
Contact
lbb135@psu.edu
814-865-5246
Emily E Hohman, PhD
principal investigator · Penn State University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion